We are proud to share with you that the trademark “NOL NOCICEPTION LEVEL INDEX” is approved and registered as Medasense’s trademark in Europe and in the U.S.!
Medasense Welcomes Holly Stewart as VP of Sales, North America
December 4, 2023
Newsdesk
Follow Medasense’s accomplishments and news
Top Posts
FDA Commissioner Highlights Marketing Authorization of NOL Technology
September 21, 2023
Now in the U.S. – Meet us at U.S. conferences
August 30, 2023
Pain News Network publishes article on Medasense
April 13, 2023